Zenlabs Ethica Ltd
Zenlabs Ethica Ltd (ZENLABS) last reported results for the quarter ended Jun 2026, with sales of ₹14.18 crore and net profit of ₹-0.57 crore. The stock last traded at ₹27, a market capitalisation of ₹17.6 crore. Over the past 52 weeks the stock has ranged between ₹16.5 and ₹40. Figures are as of 6 Oct 2026 and are not real time.
Zenlabs Ethica Ltd share price and key metrics
- Current price
- ₹27
- Market cap
- ₹17.6 cr
- Book value
- ₹13.1
- ROE
- 0.21%
- ROCE
- 5.07%
- Dividend yield
- 0.00%
- 52w high / low
- 40.0/16.5
Metrics as of 6 Oct 2026. Not real time.
Track Zenlabs Ethica Ltd
Cruxal reads every Zenlabs Ethica Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Zenlabs Ethica Ltd growth and returns
- 10 Years
- 12%
- 5 Years
- -4%
- 3 Years
- -11%
- TTM
- -2%
- 10 Years
- -23%
- 5 Years
- -52%
- 3 Years
- -72%
- TTM
- -277%
- 10 Years
- 4%
- 5 Years
- -5%
- 3 Years
- -10%
- 1 Year
- -14%
- 10 Years
- 7%
- 5 Years
- 5%
- 3 Years
- 2%
- Last Year
- 0%
Zenlabs Ethica Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹14.18 cr, up 23.5% from ₹11.48 cr a year earlier. Net profit swung to a loss of ₹0.57 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 13.35 | 12.72 | 12.99 | 11.48 | 12.43 | 12.43 | 10.58 | 14.18 |
| Expenses | 12.73 | 12.04 | 12.33 | 10.93 | 11.98 | 11.91 | 10.31 | 14.47 |
| Operating profit | 0.62 | 0.68 | 0.66 | 0.55 | 0.45 | 0.52 | 0.27 | -0.29 |
| OPM % | 4.64% | 5.35% | 5.08% | 4.79% | 3.62% | 4.18% | 2.55% | -2.05% |
| Other income | 0 | 0 | 0.04 | 0 | 0.06 | -2.08 | 0.12 | 0 |
| Interest | 0.23 | 0.24 | 0.23 | 0.21 | 0.19 | 0.23 | 0.18 | 0.16 |
| Depreciation | 0.31 | 0.32 | 0.31 | 0.29 | 0.24 | 0.23 | 0.14 | 0.11 |
| Profit before tax | 0.08 | 0.12 | 0.16 | 0.05 | 0.08 | -2.02 | 0.07 | -0.56 |
| Tax % | 25.00% | 33.33% | 43.75% | 20.00% | 50.00% | 0.00% | 114.29% | 3.57% |
| Net profit | 0.05 | 0.09 | 0.09 | 0.03 | 0.04 | -2.01 | 0 | -0.57 |
| EPS (₹) | 0.08 | 0.14 | 0.14 | 0.05 | 0.06 | -3.09 | 0.00 | -0.88 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Zenlabs Ethica Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 78.73 | 69.85 | 65.37 | 58.5 | 56.64 | 69.09 | 66.89 | 58.56 | 51.42 | 46.92 | 49.62 |
| Operating profit | 1.45 | 1.85 | 2.09 | -0.7 | 1.75 | 2.39 | 2.91 | 2.41 | 2.58 | 1.79 | 0.95 |
| OPM % | 1.84% | 2.65% | 3.20% | -1.20% | 3.09% | 3.46% | 4.35% | 4.12% | 5.02% | 3.82% | 1.91% |
| Net profit | 0.95 | 1.16 | 1.26 | -0.73 | 0.77 | 0.78 | 0.49 | 0.42 | 0.27 | -1.94 | -2.54 |
| EPS (₹) | 1.46 | 1.78 | 1.94 | -1.12 | 1.18 | 1.20 | 0.75 | 0.65 | 0.41 | -2.98 | -3.91 |
TTM is the trailing twelve months to the most recent quarter.
Zenlabs Ethica Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 6.20 | 6.20 | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 |
| Reserves | -0.41 | 0.81 | 1.77 | 0.90 | 2.05 | 2.82 | 3.19 | 3.61 | 3.92 | 2.00 |
| Borrowings | 0.96 | 0.85 | 0.60 | 0.73 | 2.60 | 3.90 | 5.85 | 14.86 | 12.71 | 10.98 |
| Other liabilities | 26.62 | 21.96 | 26.01 | 25.85 | 21.04 | 24.66 | 27.95 | 15.28 | 17.48 | 17.71 |
| Total liabilities | 33.37 | 29.82 | 34.89 | 33.99 | 32.20 | 37.89 | 43.50 | 40.26 | 40.62 | 37.20 |
| Fixed assets | 1.50 | 1.33 | 1.36 | 1.12 | 3.51 | 3.53 | 5.03 | 3.70 | 2.29 | 1.87 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.95 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | 0.00 |
| Other assets | 30.92 | 27.79 | 32.83 | 32.17 | 27.99 | 33.66 | 37.77 | 35.86 | 37.63 | 35.33 |
| Total assets | 33.37 | 29.82 | 34.89 | 33.99 | 32.20 | 37.89 | 43.50 | 40.26 | 40.62 | 37.20 |
As reported by the company. Total assets equal total liabilities by construction.
Zenlabs Ethica Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.06 | 0.36 | 0.80 | 0.45 | -8.41 | -0.38 | 1.52 | -9.06 | 3.83 | 4.06 |
| Cash from investing | -0.02 | -0.03 | -0.22 | 0.01 | 0.15 | 0.00 | -1.47 | 0.11 | 0.14 | 0.00 |
| Cash from financing | -0.27 | -0.23 | -0.14 | -0.03 | -0.52 | 0.31 | 0.06 | 8.24 | -3.08 | -2.95 |
| Net cash flow | -1.35 | 0.09 | 0.44 | 0.43 | -8.78 | -0.07 | 0.11 | -0.71 | 0.88 | 1.11 |
| Free cash flow | -1.08 | 0.33 | 0.49 | 0.40 | -8.35 | -0.41 | -0.03 | -9.08 | 3.96 | 4.06 |
| CFO / operating profit | -73% | 19% | 38% | -64% | -475% | -11% | 62% | -371% | 157% | 234% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Zenlabs Ethica Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 21.06% | 23.96% | 24.13% | -11.05% | 12.02% | 13.04% | 12.44% | 7.01% | 5.69% | 5.07% |
| Debtor days | 107.65 | 126.40 | 139.37 | 138.76 | 121.67 | 109.57 | 118.41 | 129.21 | 138.70 | 122.13 |
| Inventory days | 34.42 | 11.12 | 31.23 | 33.95 | 40.46 | 56.05 | 77.85 | 100.05 | 128.43 | 161.14 |
| Days payable | 136.41 | 125.88 | 161.27 | 165.31 | 150.28 | 141.30 | 174.04 | 101.21 | 140.00 | 165.22 |
| Cash conversion cycle | 5.66 | 11.64 | 9.33 | 7.40 | 11.85 | 24.32 | 22.21 | 128.04 | 127.13 | 118.05 |
| Working capital days | 13.40 | 21.95 | 28.42 | 24.02 | 27.97 | 35.34 | 34.98 | 47.31 | 52.74 | 39.44 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Zenlabs Ethica Ltd shareholding pattern
Promoters held 52.96% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 52.96% | 52.96% | 52.96% | 52.96% | 52.96% | 52.96% | 52.96% | 52.96% |
| Public | 47.04% | 47.04% | 47.04% | 47.03% | 47.04% | 47.04% | 47.05% | 47.04% |
| No. of shareholders | 2,635 | 2,630 | 2,663 | 2,648 | 2,712 | 2,774 | 2,756 | 2,717 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Zenlabs Ethica Ltd corporate filings
- Zenlabs Ethica Limited announces resignation of Company Secretary & Compliance Officer effective October 5, 2026, with no immediate financial impact disclosedCompany Updatelow impact
Cruxal's analysis: Zenlabs Ethica Limited has formally communicated the resignation of Mr. Nikunj Goel, its…
Read the full analysis - Zenlabs Ethica Limited conducts AGM with full shareholder approval on key resolutions including financials, reappointment of directors, appointment of auditors, and amendments to the MOA, with over 99.97% voting in favor on all resolutions.AGM/EGMmedium impact
Cruxal's analysis: Zenlabs Ethica Limited held its 33rd AGM on September 29, 2026, with a total of…
Read the full analysis - Reappointment of M/s N Kumar Chabbra & Co., chartered accountants (FRN: 000873N) as the statutory auditor of the company.Company Updatemedium impact
- Intimation regarding the alteration of MOA of the company.Company Updatelow impact
- Revised Proceeding/Outcome of the 33rd Annual General Meeting of Zenlabs Ethica Limited held on 29th September, 2026.AGM/EGMmedium impact
- Proceedings/outcome of the 33rd Annual General Meeting of Zenlabs Ethica Limited held on 29th September, 2026.AGM/EGMmedium impact
- The trading window will remain closed for all directors/ Promoters/ Designated Persons and their immediate relatives of the company from Thursday, 1st October, 2026 till 48 hours after ....Insider Trading / SASTlow impact
- Zenlabs Ethica Ltd schedules 33rd Annual General Meeting for September 29, 2026Company Updatelow impact
Cruxal's analysis: Zenlabs Ethica Ltd has issued a post-notice advertisement regarding its 33rd Annual…
Read the full analysis - Zenlabs Ethica Ltd dispatches annual report for FY 2025-26 to shareholdersCompany Updatelow impact
Cruxal's analysis: Zenlabs Ethica Ltd has initiated the dispatch of its annual report for the financial year…
Read the full analysis - Zenlabs Ethica Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Zenlabs Ethica Ltd has filed its Annual Report for the financial year 2025-26. The…
Read the full analysis - Zenlabs Ethica Limited Announces 33rd AGM and Proposes Expansion of Object ClauseAGM/EGMlow impact
Cruxal's analysis: Zenlabs Ethica Limited has scheduled its 33rd Annual General Meeting for September 29…
Read the full analysis - Zenlabs Ethica Ltd schedules 33rd Annual General Meeting for September 29, 2026Company Updatelow impact
Cruxal's analysis: Zenlabs Ethica Ltd has published newspaper advertisements confirming that its 33rd Annual…
Read the full analysis - Zenlabs Ethica Limited Announces 33rd AGM and Broad Amendment to Memorandum of AssociationOtherslow impact
Cruxal's analysis: Zenlabs Ethica Limited has scheduled its 33rd Annual General Meeting for September 29…
Read the full analysis - Zenlabs Ethica Limited publishes newspaper advertisement for un-audited financial results for the quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Zenlabs Ethica Limited has complied with SEBI (Listing Obligations and Disclosure…
Read the full analysis - Zenlabs Ethica Limited reports net loss of 57.12 lakh for Q1 FY27 amid rising inventory costsBoard Meetinghigh impact
Cruxal's analysis: Zenlabs Ethica Limited reported a net loss of 57.12 lakh for the quarter ended 30 June…
Read the full analysis - Zenlabs Ethica Ltd enters into a business agreement with V Nexxtra Lifesciences Private LimitedCompany Updatelow impact
Cruxal's analysis: Zenlabs Ethica Ltd has formally announced a business agreement with V Nexxtra…
Read the full analysis - Zenlabs Ethica Limited schedules Board Meeting for August 12, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Zenlabs Ethica Limited has formally intimated the BSE regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.